Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-inflammatory Effect of IV vs SC Heparin in Sepsis
NCT04313790Phase 2Completed
- Sponsor
- Damanhour University
- Start
- Aug 2020
- Primary completion
- Oct 2022
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of heparin in sepsis, sponsored by Damanhour University. Started Aug 2020; status: completed.
02
Drugs
heparin
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT04313790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04313790.